ISS, Glass Lewis, and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split

Author's Avatar
Oct 19, 2022

Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the three leading, independent proxy advisory firms - Institutional Shareholder Services (ISS), Glass Lewis and Co, LLC, and Egan-Jones & Co - all recommend that shareholders vote “For” Proposal 2, Reverse Stock Split, at Acorda’s Special Meeting of Stockholders, scheduled for November 4, 2022.